Common Contracts
3 similar Clinical Development Agreement contracts by Vion Pharmaceuticals Inc, Ista Pharmaceuticals Inc
1 EXHIBIT 10.6 CLINICAL DEVELOPMENT AGREEMENT PROTOCOL #VIT-02-08961X AND PROTOCOL #VIT-03-08961X: Two Phase III Safety and Efficacy Studies of Vitrase(TM) (Hyaluronidase for Ophthalmic Intravitreal Injection) for Clearance of Severe Vitreous...Clinical Development Agreement • April 5th, 2000 • Ista Pharmaceuticals Inc • New Jersey
EXHIBIT 10.33 ------------- CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH REGARD TO PORTIONS OF THIS EXHIBIT AMENDMENT TO CLINICAL DEVELOPMENT AGREEMENT This Amendment is entered into this 27th day of October, 1999 by and between Vion...Clinical Development Agreement • March 30th, 2000 • Vion Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Confidential treatment has been requested for portions of this exhibit. The confidential portions are designated by brackets [ ]. CLINICAL DEVELOPMENT AGREEMENT (this "Agreement") between VION PHARMACEUTICALS INC.("The Sponsor") FOUR SCIENCE PARK NEW...Clinical Development Agreement • August 14th, 1997 • Vion Pharmaceuticals Inc • Biological products, (no disgnostic substances)
